These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19221371)

  • 1. Using a drug facts box to communicate drug benefits and harms: two randomized trials.
    Schwartz LM; Woloshin S; Welch HG
    Ann Intern Med; 2009 Apr; 150(8):516-27. PubMed ID: 19221371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.
    O'Donoghue ML; Braunwald E; Antman EM; Murphy SA; Bates ER; Rozenman Y; Michelson AD; Hautvast RW; Ver Lee PN; Close SL; Shen L; Mega JL; Sabatine MS; Wiviott SD
    Lancet; 2009 Sep; 374(9694):989-997. PubMed ID: 19726078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
    Furuta T
    Intern Med; 2009; 48(21):1847-8. PubMed ID: 19881232
    [No Abstract]   [Full Text] [Related]  

  • 5. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controversy regarding the concomitant use of clopidogrel and proton pump inhibitors (PPI)].
    Calderón Hernanz B; Pinteño Blanco M; Puigventos Latorre F; Martínez López I
    Farm Hosp; 2009; 33(6):339-40. PubMed ID: 20038396
    [No Abstract]   [Full Text] [Related]  

  • 7. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.
    Wu CY; Chan FK; Wu MS; Kuo KN; Wang CB; Tsao CR; Lin JT
    Gastroenterology; 2010 Oct; 139(4):1165-71. PubMed ID: 20600012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Drug Facts Box: Improving the communication of prescription drug information.
    Schwartz LM; Woloshin S
    Proc Natl Acad Sci U S A; 2013 Aug; 110 Suppl 3(Suppl 3):14069-74. PubMed ID: 23942130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
    Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
    Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
    Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
    Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and effectiveness of combining clopidogrel and proton pump inhibitors].
    Calderón Hernanz B; Pinteño Blanco M; Puigventos Latorre F; Martínez-López I
    Farm Hosp; 2009; 33(6):338-9. PubMed ID: 20038395
    [No Abstract]   [Full Text] [Related]  

  • 17. Clopidogrel-drug interactions.
    Bates ER; Lau WC; Angiolillo DJ
    J Am Coll Cardiol; 2011 Mar; 57(11):1251-63. PubMed ID: 21392639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.
    Sullivan HW; Campbell M
    J Health Commun; 2015; 20(12):1391-6. PubMed ID: 26120940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review.
    Focks JJ; Brouwer MA; van Oijen MG; Lanas A; Bhatt DL; Verheugt FW
    Heart; 2013 Apr; 99(8):520-7. PubMed ID: 22851683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.